ESC Premium Access

Online session - Latest Randomized Results on Antiplatelet Therapy - Host and Discussant

Congress Presentation

About the speaker

Professor Marco Roffi

University hospitals of Geneva, Geneva (Switzerland)
33 presentations
2 followers

3 more presentations in this session

The effect of one year postoperative ticagrelor in addition to aspirin on saphenous vein graft patency in patients undergoing CABG – a randomized, multi-center, double-blind, placebo-controlled trial.

Speaker: Miss L. Willemsen (Nieuwegein, NL)

Thumbnail

Prasugrel based de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial

Speaker: Doctor H. Kim (Seoul, KR)

Thumbnail

Downstream or upstream P2Y12 receptor blockers in NSTE-ACS

Speaker: Associate Professor G. Tarantini (Padova, IT)

Thumbnail

Access the full session

Latest Randomized Results on Antiplatelet Therapy

Speakers: Professor M. Roffi, Miss L. Willemsen, Doctor H. Kim, Associate Professor G. Tarantini
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by